Literature DB >> 8475995

Suppression of local and systemic responses in streptococcal cell wall-induced acute inflammation of the air pouch by cyclosporine A. Comparison with the effects of two anti-inflammatory bis-benzimidazoles.

J Dieter Geratz1, K B Pryzwansky, J H Schwab, S K Anderle, R R Tidwell.   

Abstract

Injection of streptococcus group A cell wall-derived peptidoglycan polysaccharide into a subcutaneous air pouch causes local outpouring of neutrophils and macrophages and distant hemopoietic proliferation in spleen and bone marrow. Cyclosporine A (CyA) suppressed neutrophil accumulation and all cell lines of hemopoiesis. trans-1,2-Bis(5-amidino-2-benzimidazolyl)ethene (BBE) also interfered with neutrophil exudation, yet reduced only the erythroid component of the hemopoietic process. The ethane analogue of BBE, on the other hand, did not prevent neutrophil emigration, but held down splenic erythropoiesis and myelopoiesis. All three compounds stimulated streptococcus group A cell wall-derived peptidoglycan polysaccharide uptake by pouch macrophages. CyA being the least active, BBE and its ethane analogue also produced a shift of wear-and-tear pigment from large numbers of small splenic macro-phages into small numbers of large macrophages. The pouch model is very useful in the study of anti-inflammatory compounds and has furnished the first evidence of CyA interference with massive neutrophilic infiltration and with hemopoietic signals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8475995      PMCID: PMC1886893     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  20 in total

1.  Inhibition of leukocyte chemotaxis by immunosuppressive agents. Specific inhibition of lymphocyte chemotaxis by cyclosporine.

Authors:  D H Adams; L F Wang; J M Neuberger; E Elias
Journal:  Transplantation       Date:  1990-11       Impact factor: 4.939

2.  [Erythroblastic island, functional unity of bone marrow].

Authors:  M BESSIS
Journal:  Rev Hematol       Date:  1958 Jan-Mar

3.  The erythroblastic island: past and future.

Authors:  J Bernard
Journal:  Blood Cells       Date:  1991

4.  Bone marrow changes in adjuvant-induced and collagen-induced arthritis. Interleukin-1 and interleukin-6 activity and abnormal myelopoiesis.

Authors:  K Hayashida; T Ochi; M Fujimoto; H Owaki; Y Shimaoka; K Ono; K Matsumoto
Journal:  Arthritis Rheum       Date:  1992-02

5.  Cyclosporine and human neutrophil function.

Authors:  R L Janco; D English
Journal:  Transplantation       Date:  1983-05       Impact factor: 4.939

6.  Effects of cyclosporin A and FK506 on ischemia/reperfusion-induced neutrophil infiltration in the cat.

Authors:  P Kubes; J Hunter; D N Granger
Journal:  Dig Dis Sci       Date:  1991-10       Impact factor: 3.199

7.  Streptococcal cell wall-induced systemic disease. Beneficial effects of trans-bis(5-amidino-2-benzimidazolyl)ethene, a novel, macrophage-directed anti-inflammatory agent.

Authors:  J D Geratz; R R Tidwell; R J Lombardy; J H Schwab; S K Anderle; K B Pryzwansky
Journal:  Am J Pathol       Date:  1991-10       Impact factor: 4.307

8.  E-selectin (endothelial-leukocyte adhesion molecule-1) is not required for the migration of neutrophils across IL-1-stimulated endothelium in vitro.

Authors:  M B Furie; M J Burns; M C Tancinco; C D Benjamin; R R Lobb
Journal:  J Immunol       Date:  1992-04-15       Impact factor: 5.422

9.  Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine-specific esteroproteases.

Authors:  R R Tidwell; J D Geratz; O Dann; G Volz; D Zeh; H Loewe
Journal:  J Med Chem       Date:  1978-07       Impact factor: 7.446

10.  Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2.

Authors:  D Bunjes; C Hardt; M Röllinghoff; H Wagner
Journal:  Eur J Immunol       Date:  1981-08       Impact factor: 5.532

View more
  3 in total

1.  The peptide of sequence 66-77 of monocytic chemotactic protein (MCP-1) inhibits inflammation in experimental animals.

Authors:  T L Krasnikova; T I Arefieva; M G Melekhov; N B Kukhtina; M V Sidorova; A S Molokoedov; V N Bushuev; Zh D Bespalova; E I Chazov
Journal:  Dokl Biol Sci       Date:  2005 Sep-Oct

2.  Anti-Pneumocystis activities of aromatic diamidoxime prodrugs.

Authors:  J E Hall; J E Kerrigan; K Ramachandran; B C Bender; J P Stanko; S K Jones; D A Patrick; R R Tidwell
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

3.  Control of glucan-induced systemic granulomatosis by cyclosporine A.

Authors:  J D Geratz; K B Pryzwansky; S K Anderle; R R Tidwell
Journal:  Inflammation       Date:  1995-04       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.